Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 164   

Articles published

GSK 1,318.00 +12.00 (0.92%)
price chart
GlaxoSmithKline plc 18.5% Potential Upside Indicated by Kepler Cheuvreux
GlaxoSmithKline plc with EPIC/TICKER LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'HOLD' this morning by analysts at Kepler Cheuvreux.
Exane BNP Paribas Reconfirms a "Neutral" Rating on GlaxoSmithKline ...
GlaxoSmithKline plc Rating Reiterated by Morgan Stanley (GSK)  Dakota Financial News
GlaxoSmithKline PLC (NYSE:GSK) Analyst Price Target
GlaxoSmithKline PLC (NYSE:GSK): The mean short term price target for GlaxoSmithKline PLC (NYSE:GSK) has been established at $48.5 per share.
GlaxoSmithKline plc Receives A+ Credit Rating (GSK)  The Market Business
Shares of GlaxoSmithKline PLC (NYSE:GSK) Sees Large Inflow of Net Money Flow  OTC Outlook
3 Hot European Stocks For Investors: GlaxoSmithKline plc (ADR) (NYSE:GSK ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) surged 0.19% and closed the last trading session at $40.24. Its 52-Week range is from $37.24 to $49.08.
Earnings of $0.6 Expected for GlaxoSmithKline PLC (NYSE:GSK)'s Q2  Markets Daily
What's The Number One Difference Between GlaxoSmithKline plc And AstraZeneca plc?
Investors often lump similar companies from the same sector together, and as a first pass at categorizing the thousands of companies out there, that's understandable.
Company Shares of GlaxoSmithKline PLC (NYSE:GSK) Drops by -0.72%  Insider Trading Report
GlaxoSmithKline plc Receives $47.00 Consensus Target Price from Brokerages ...  Financial Wisdom Works
GlaxoSmithKline plc Given Neutral Rating at BNP Paribas (GSK)
BNP Paribas restated their neutral rating on shares of GlaxoSmithKline plc (LON:GSK) in a report issued on Tuesday, StockTargetPrices.
GlaxoSmithKline PLC (LON:GSK) Investors: Exane BNP Paribas Reiterates ...
GlaxoSmithKline plc Earns Equalwt/In-Line Rating from Morgan Stanley (GSK)  Financial Wisdom Works
GlaxoSmithKline plc (ADR), AbbVie Inc: Attractive High-Yield Dividend Pharma ...
yield Bob Ciura: The stock market sell-off is painful for investors who own stocks, but the good news is that declining stock prices present new buying opportunities.
Analysts at Exane BNP Paribas Maintain their Neutral rating for ...
In an analyst note sent to investors and clients on today, Exane BNP Paribas restate their Neutral rating on GlaxoSmithKline PLC (LON:GSK)'s stock. The target price per share indicates a potential upside of 14.79% from firm's last stock price. LON:GSK ...
GlaxoSmithKline plc 13.4% Potential Upside Indicated by Exane BNP Paribas  DirectorsTalk Interviews
GlaxoSmithKline plc insider Purchases �6567.75 in Stock (GSK)  Dakota Financial News
Company Shares of GlaxoSmithKline PLC (NYSE:GSK) Drops by -3.73%
GlaxoSmithKline PLC (NYSE:GSK) has lost 3.73% during the past week and dropped 6.72% in the last 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 2.4%.
GlaxoSmithKline plc's "Neutral" Rating Reiterated at BNP ...  Mideast Time
GlaxoSmithKline plc Assigned A+ Credit Rating (GSK)  Financial Wisdom Works
GlaxoSmithKline plc (GSK) Circles 52-Week Low; How The Giant Got Here And What ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) is trading near its 52-week low after having lost 5.91% of its value this year. The NYSE ARCA Pharmaceutical Index (DRG) gained 3.02% during the same timeframe.
GlaxoSmithKline PLC (NYSE:GSK) Analyst Rating Update  Money Flow Index
GlaxoSmithKline PLC Price Target Update  American Trade Journal
This Coule Be GlaxoSmithKline plc (ADR) (GSK)'s Most Important News for Sep, 30
therapeutics - Liquidia Technologies announced that GlaxoSmithKline has exercised its option under a Collaboration and Option Agreement signed in 2012 to exclusively license the right to research, develop, and commercialize inhaled therapeutics derived ...